Skip to main content
. 2024 Dec 12;36(1):102423. doi: 10.1016/j.omtn.2024.102423

Figure 1.

Figure 1

In vitro delivery of FANCC LNPs to correct FA-deficient BM-derived HSPCs

(A) Transmitted images of Lin whole bone marrow (BM) from Fancc−/− mutant mice in methylcellulose media after treatment with LNP and 20 nM mitomycin C (MMC). (B) Colony survival rates expressed as a percentage ratio of the number of colonies formed after exposure to MMC and of colonies formed without MMC treatment across a range of treatments. (C) Percentage ratios of the sum of colony spread area of colonies in (B). (D) Transmitted images of ex vivo expanded LT-HSCs from Fancc−/− mice in methylcellulose media after treatment with LNP and 30 nM MMC. (E and F) Colony survival rates of Fancc−/− or WT ex vivo expanded LT-HSCs after pre-treatment with 30 nM MMC and LNPLFancc or LNPCFancc. Data points represent biological replicates (p < 0.05).